Skip to main content
. 2020 May 1;18:117. doi: 10.1186/s12955-020-01372-6

Fig. 2.

Fig. 2

ALSAQ-40 and clinical parameters. a The non-parametric regression Loess (Epanechnikov) was used to visualize the behavior of the ALSAQ-40 SI and emotional well-being across the rD50-derived disease phases in the cross-sectional data. b Mean values of ALSAQ-40 SI and emotional well-being at baseline and first (6 months) and second (12 months) follow ups